Questionnaire Survey on Adoption and Prescription of Biosimilars (Antibody and Its-related Products) by Medical Doctors in Japan

Author:

Aoki Yoshiko1,Sai Kimie1,Katsuta Yukiko1,Suzuki Mika1,Suzuki Yasuo2,Ishii-Watabe Akiko3,Saito Yoshiro1

Affiliation:

1. Division of Medicinal Safety Science, National Institute of Health Sciences

2. IBD Center, Toho University Sakura Medical Center

3. Division of Biological Chemistry and Biologicals, National Institute of Health Sciences

Publisher

Pharmaceutical Society of Japan

Subject

Pharmaceutical Science,Pharmacology

Reference19 articles.

1. 1) Ministry of Health, Labour and Welfare, Head of Pharmaceutical Evaluation Division, Pharmaceutical Safety and Environmental Health Bureau, “Guidelines for ensuring the quality, safety, and efficacy of subsequent biologics.”: 〈https://www.mhlw.go.jp/hourei/doc/tsuchi/T20200206I0010.pdf〉, cited 24 September, 2021.

2. 2) Japan Cabinet Office, “Basic policy of economic and financial management and reform 2019.”: 〈https://www5.cao.go.jp/keizai-shimon/kaigi/cabinet/2019/2019_basicpolicies_ja.pdf〉, cited 24 September, 2021.

3. 3) Akabane H., Regul. Sci. Med. Prod., 8, 35-43 (2018).

4. 4) Leonard E., Wascovich M., Oskouei S., Gurz P., Carpenter D., J. Manag. Care Spec. Pharm., 25, 102-112 (2019).

5. 5) May M. B., Taucher K. D., Vogel W. H., J. Adv. Pract. Oncol., 12, 431-438 (2021).

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3